| Product Code: ETC6744058 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Geriatric Medicines Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Geriatric Medicines Market Revenues & Volume, 2021 & 2031F |
3.3 China Geriatric Medicines Market - Industry Life Cycle |
3.4 China Geriatric Medicines Market - Porter's Five Forces |
3.5 China Geriatric Medicines Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 China Geriatric Medicines Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 China Geriatric Medicines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 China Geriatric Medicines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 China Geriatric Medicines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Geriatric Medicines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in China |
4.2.2 Rising prevalence of chronic diseases among geriatric population |
4.2.3 Government initiatives to improve healthcare services for elderly individuals |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in rural areas |
4.3.2 High cost of geriatric medicines and treatments |
4.3.3 Lack of awareness about geriatric healthcare among the population |
5 China Geriatric Medicines Market Trends |
6 China Geriatric Medicines Market, By Types |
6.1 China Geriatric Medicines Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 China Geriatric Medicines Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 China Geriatric Medicines Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.1.4 China Geriatric Medicines Market Revenues & Volume, By Arthritis, 2021- 2031F |
6.1.5 China Geriatric Medicines Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.1.6 China Geriatric Medicines Market Revenues & Volume, By Neurological, 2021- 2031F |
6.1.7 China Geriatric Medicines Market Revenues & Volume, By Cancer, 2021- 2031F |
6.1.8 China Geriatric Medicines Market Revenues & Volume, By Osteoporosis, 2021- 2031F |
6.1.9 China Geriatric Medicines Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 China Geriatric Medicines Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Geriatric Medicines Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 China Geriatric Medicines Market Revenues & Volume, By Analgesic, 2021- 2031F |
6.2.3 China Geriatric Medicines Market Revenues & Volume, By Antihypertensive, 2021- 2031F |
6.2.4 China Geriatric Medicines Market Revenues & Volume, By Statins, 2021- 2031F |
6.2.5 China Geriatric Medicines Market Revenues & Volume, By Antidiabetic, 2021- 2031F |
6.2.6 China Geriatric Medicines Market Revenues & Volume, By Proton Pump Inhibitor, 2021- 2031F |
6.2.7 China Geriatric Medicines Market Revenues & Volume, By Anticoagulant, 2021- 2031F |
6.3 China Geriatric Medicines Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 China Geriatric Medicines Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 China Geriatric Medicines Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 China Geriatric Medicines Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Geriatric Medicines Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 China Geriatric Medicines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 China Geriatric Medicines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 China Geriatric Medicines Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 China Geriatric Medicines Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Geriatric Medicines Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 China Geriatric Medicines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 China Geriatric Medicines Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 China Geriatric Medicines Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 China Geriatric Medicines Market Import-Export Trade Statistics |
7.1 China Geriatric Medicines Market Export to Major Countries |
7.2 China Geriatric Medicines Market Imports from Major Countries |
8 China Geriatric Medicines Market Key Performance Indicators |
8.1 Average length of hospital stay for geriatric patients |
8.2 Number of geriatric healthcare facilities in China |
8.3 Percentage of elderly population receiving regular healthcare check-ups |
9 China Geriatric Medicines Market - Opportunity Assessment |
9.1 China Geriatric Medicines Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 China Geriatric Medicines Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 China Geriatric Medicines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 China Geriatric Medicines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 China Geriatric Medicines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Geriatric Medicines Market - Competitive Landscape |
10.1 China Geriatric Medicines Market Revenue Share, By Companies, 2024 |
10.2 China Geriatric Medicines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here